As per corporate shareholdings filed for Jan-2025, people matching Rowe Price Health Sciences Fund publicly holds 137 stocks with a net worth of over US$ 11.7 B.
These are shares held by Rowe Price Health Sciences Fund as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
---|---|---|---|---|---|---|---|---|
Mirati Therapeutics Inc | T. Rowe Price Health Sciences Fund | 58.70 | 1,239,528 | 1.77% | 0.00 | 72.8 M | ||
Reata Pharmaceuticals Inc - Ordinary Shares - Class A | T. Rowe Price Health Sciences Fund | 172.36 | 72,200 | 0.19% | 0.00 | 12.4 M | ||
Karuna Therapeutics Inc | T. Rowe Price Health Sciences Fund | 329.83 | 471,717 | 1.24% | 0.00 | 155.6 M | ||
Alpine Immune Sciences Inc | T. Rowe Price Health Sciences Fund | 7.80 | 704,161 | 1.07% | 0.00 | 5.5 M | ||
ShockWave Medical Inc | T. Rowe Price Health Sciences Fund | 0.00 | 348,303 | 0.93% | 0.00 | - | ||
Morphic Holding Inc | T. Rowe Price Health Sciences Fund | 56.99 | 621,518 | 1.24% | 0.00 | 35.4 M | ||
BeiGene Ltd - ADR | T. Rowe Price Health Sciences Fund | 261.10 | 753,617 | 0.71% | 0.00 | 196.8 M | ||
Agilent Technologies Inc. | T. Rowe Price Health Sciences Fund | 116.21 | 499,123 | 0.18% | 0.00 | 58.0 M | ||
Arcellx Inc | T. Rowe Price Health Sciences Fund | 63.33 | 864,390 | 1.57% | -0.07 | 54.7 M | ||
Agios Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 28.92 | 1,073,549 | 1.87% | -0.55 | 31.0 M | ||
Akero Therapeutics Inc | T. Rowe Price Health Sciences Fund | 39.98 | 1,261,955 | 1.58% | 0.30 | 50.5 M | ||
Alector Inc | T. Rowe Price Health Sciences Fund | 1.23 | 434,596 | 0.44% | -0.05 | 534.6 K | ||
Alkermes plc | T. Rowe Price Health Sciences Fund | 32.73 | 1,171,579 | 0.72% | -0.04 | 38.3 M | ||
Allogene Therapeutics Inc | T. Rowe Price Health Sciences Fund | 1.45 | 2,980,431 | 1.40% | -0.16 | 4.3 M | ||
Alnylam Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 265.20 | 1,283,825 | 0.99% | 0.01 | 340.5 M | ||
AMGEN Inc. | T. Rowe Price Health Sciences Fund | 314.12 | 691,266 | 0.13% | -0.02 | 217.1 M | ||
AnaptysBio Inc | T. Rowe Price Health Sciences Fund | 18.46 | 51,053 | 0.17% | -0.98 | 942.4 K | ||
Annexon Inc | T. Rowe Price Health Sciences Fund | 2.10 | 668,879 | 0.61% | NEW | 1.4 M | ||
Apogee Therapeutics Inc. | T. Rowe Price Health Sciences Fund | 37.09 | 818,665 | 1.41% | 0.44 | 30.4 M | ||
Apellis Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 22.65 | 188,820 | 0.15% | -0.02 | 4.3 M | ||
Argen X SE - ADR | T. Rowe Price Health Sciences Fund | 579.45 | 771,638 | 1.27% | -0.06 | 447.1 M | ||
Arvinas Inc | T. Rowe Price Health Sciences Fund | 7.08 | 429,274 | 0.62% | 0.02 | 3.0 M | ||
Ascendis Pharma A/S - ADR | T. Rowe Price Health Sciences Fund | 149.39 | 985,726 | 1.65% | 0.04 | 147.3 M | ||
Aura Biosciences Inc | T. Rowe Price Health Sciences Fund | 5.86 | 354,888 | 0.71% | -0.07 | 2.1 M | ||
Astrazeneca plc - ADR | T. Rowe Price Health Sciences Fund | 72.64 | 4,146,935 | 0.13% | 0.00 | 301.2 M | ||
Bicycle Therapeutics Plc - ADR | T. Rowe Price Health Sciences Fund | 8.41 | 1,186,115 | 1.71% | -0.19 | 10.0 M | ||
Becton, Dickinson And Co. | T. Rowe Price Health Sciences Fund | 228.20 | 607,915 | 0.21% | -0.03 | 138.7 M | ||
Biohaven Ltd | T. Rowe Price Health Sciences Fund | 24.48 | 1,812,566 | 1.78% | -0.16 | 44.4 M | ||
Biogen Inc | T. Rowe Price Health Sciences Fund | 137.32 | 154,545 | 0.11% | -0.01 | 21.2 M | ||
Blueprint Medicines Corp | T. Rowe Price Health Sciences Fund | 86.85 | 1,770,260 | 2.77% | 0.06 | 153.7 M | ||
Bruker Corp | T. Rowe Price Health Sciences Fund | 41.41 | 280,131 | 0.18% | 0.00 | 11.6 M | ||
Boston Scientific Corp. | T. Rowe Price Health Sciences Fund | 99.76 | 3,862,630 | 0.26% | 0.01 | 385.3 M | ||
BrightSpring Health Services Inc | T. Rowe Price Health Sciences Fund | 18.02 | 1,857,598 | 1.07% | -0.10 | 33.5 M | ||
Cabaletta Bio Inc | T. Rowe Price Health Sciences Fund | 1.39 | 327,343 | 0.67% | NEW | 455.0 K | ||
Cardinal Health, Inc. | T. Rowe Price Health Sciences Fund | 137.62 | 346,950 | 0.14% | -0.01 | 47.7 M | ||
Cg Oncology Inc. | T. Rowe Price Health Sciences Fund | 25.02 | 410,204 | 0.54% | NEW | 10.3 M | ||
Cigna Group (The) | T. Rowe Price Health Sciences Fund | 329.40 | 605,095 | 0.22% | -0.04 | 199.3 M | ||
Celldex Therapeutics Inc. | T. Rowe Price Health Sciences Fund | 18.07 | 603,446 | 0.91% | -0.09 | 10.9 M | ||
Centene Corp. | T. Rowe Price Health Sciences Fund | 60.69 | 846,190 | 0.17% | 0.04 | 51.4 M | ||
Centessa Pharmaceuticals plc - ADR | T. Rowe Price Health Sciences Fund | 14.16 | 3,480,378 | 2.62% | 0.23 | 49.3 M | ||
Cencora Inc. | T. Rowe Price Health Sciences Fund | 279.29 | 160,606 | 0.08% | -0.01 | 44.9 M | ||
CARGO Therapeutics Inc | T. Rowe Price Health Sciences Fund | 4.12 | 461,811 | 1.00% | -1.48 | 1.9 M | ||
Crinetics Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 32.53 | 1,028,057 | 1.10% | -0.16 | 33.4 M | ||
Cytokinetics Inc | T. Rowe Price Health Sciences Fund | 41.69 | 456,771 | 0.39% | -0.43 | 19.0 M | ||
Day One Biopharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 7.66 | 42,500 | 0.04% | 0.00 | 325.6 K | ||
Quest Diagnostics, Inc. | T. Rowe Price Health Sciences Fund | 169.63 | 323,858 | 0.29% | 0.03 | 54.9 M | ||
Danaher Corp. | T. Rowe Price Health Sciences Fund | 202.24 | 2,050,781 | 0.29% | -0.01 | 414.7 M | ||
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A | T. Rowe Price Health Sciences Fund | 5.71 | 29,992 | 0.05% | -0.01 | 171.3 K | ||
Denali Therapeutics Inc | T. Rowe Price Health Sciences Fund | 13.63 | 1,851,072 | 1.27% | 0.19 | 25.2 M | ||
Dexcom Inc | T. Rowe Price Health Sciences Fund | 67.01 | 520,078 | 0.13% | 0.04 | 34.9 M | ||
Dyne Therapeutics Inc | T. Rowe Price Health Sciences Fund | 10.01 | 235,774 | 0.21% | -0.27 | 2.4 M | ||
Encompass Health Corp | T. Rowe Price Health Sciences Fund | 100.45 | 65,590 | 0.07% | NEW | 6.6 M | ||
Elevance Health Inc | T. Rowe Price Health Sciences Fund | 437.00 | 614,011 | 0.27% | -0.05 | 268.3 M | ||
Edwards Lifesciences Corp | T. Rowe Price Health Sciences Fund | 71.87 | 585,979 | 0.10% | -0.02 | 42.1 M | ||
Exact Sciences Corp. | T. Rowe Price Health Sciences Fund | 43.27 | 1,199,559 | 0.65% | -0.01 | 51.9 M | ||
EyePoint Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 5.47 | 344,841 | 0.50% | -0.19 | 1.9 M | ||
Generation Bio Co | T. Rowe Price Health Sciences Fund | 0.41 | 1,547,414 | 2.31% | -0.18 | 634.4 K | ||
Monte Rosa Therapeutics Inc | T. Rowe Price Health Sciences Fund | 4.65 | 1,133,275 | 1.84% | -0.18 | 5.3 M | ||
Structure Therapeutics Inc - ADR | T. Rowe Price Health Sciences Fund | 17.95 | 409,743 | 0.71% | -0.27 | 7.4 M | ||
HCA Healthcare Inc | T. Rowe Price Health Sciences Fund | 346.61 | 311,727 | 0.13% | -0.01 | 108.0 M | ||
Helix Acquisition Corp. II - Ordinary Shares - Class A | T. Rowe Price Health Sciences Fund | 10.85 | 878,945 | 3.74% | NEW | 9.5 M | ||
Humana Inc. | T. Rowe Price Health Sciences Fund | 264.10 | 74,644 | 0.06% | -0.05 | 19.7 M | ||
Icon Plc | T. Rowe Price Health Sciences Fund | 170.62 | 68,305 | 0.08% | -0.07 | 11.7 M | ||
Idexx Laboratories, Inc. | T. Rowe Price Health Sciences Fund | 416.00 | 117,676 | 0.14% | 0.00 | 49.0 M | ||
Ideaya Biosciences Inc | T. Rowe Price Health Sciences Fund | 16.55 | 186,117 | 0.21% | -0.20 | 3.1 M | ||
Immunocore Holdings plc - ADR | T. Rowe Price Health Sciences Fund | 29.46 | 1,040,185 | 2.08% | -0.20 | 30.6 M | ||
Immunome Inc | T. Rowe Price Health Sciences Fund | 6.57 | 2,313,005 | 2.73% | 0.10 | 15.2 M | ||
Immuneering Corp - Ordinary Shares Class A | T. Rowe Price Health Sciences Fund | 1.65 | 438,359 | 1.41% | -0.14 | 723.3 K | ||
Insmed Inc | T. Rowe Price Health Sciences Fund | 76.00 | 2,679,702 | 1.48% | 0.01 | 203.7 M | ||
Ionis Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 30.20 | 646,953 | 0.41% | -0.15 | 19.5 M | ||
Iovance Biotherapeutics Inc | T. Rowe Price Health Sciences Fund | 3.33 | 798,745 | 0.24% | -0.08 | 2.7 M | ||
Disc Medicine Inc | T. Rowe Price Health Sciences Fund | 49.45 | 306,817 | 0.89% | -0.07 | 15.2 M | ||
Intuitive Surgical Inc | T. Rowe Price Health Sciences Fund | 487.59 | 1,424,099 | 0.40% | -0.01 | 694.4 M | ||
Krystal Biotech Inc | T. Rowe Price Health Sciences Fund | 179.00 | 269,981 | 0.94% | 0.17 | 48.3 M | ||
Kymera Therapeutics Inc | T. Rowe Price Health Sciences Fund | 28.13 | 1,325,874 | 2.04% | 0.12 | 37.3 M | ||
Legend Biotech Corp - ADR | T. Rowe Price Health Sciences Fund | 33.14 | 639,893 | 0.35% | -0.01 | 21.2 M | ||
Lilly(Eli) & Co | T. Rowe Price Health Sciences Fund | 805.43 | 1,577,833 | 0.18% | -0.02 | 1.3 B | ||
Lantheus Holdings Inc | T. Rowe Price Health Sciences Fund | 96.70 | 249,794 | 0.36% | 0.09 | 24.2 M | ||
Lyell Immunopharma Inc | T. Rowe Price Health Sciences Fund | 0.53 | 4,648,374 | 1.58% | -0.17 | 2.5 M | ||
MBX Biosciences Inc. | T. Rowe Price Health Sciences Fund | 7.46 | 712,634 | 2.13% | 0.00 | 5.3 M | ||
Mckesson Corporation | T. Rowe Price Health Sciences Fund | 673.68 | 59,018 | 0.05% | 0.00 | 39.8 M | ||
Madrigal Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 322.78 | 146,432 | 0.66% | -0.10 | 47.3 M | ||
MoonLake Immunotherapeutics - Ordinary Shares - Class A | T. Rowe Price Health Sciences Fund | 38.28 | 1,560,826 | 2.47% | 0.19 | 59.7 M | ||
Molina Healthcare Inc | T. Rowe Price Health Sciences Fund | 329.00 | 285,071 | 0.51% | -0.04 | 93.8 M | ||
Merck & Co Inc | T. Rowe Price Health Sciences Fund | 89.18 | 3,030,115 | 0.12% | -0.02 | 270.2 M | ||
Merus N.V | T. Rowe Price Health Sciences Fund | 40.55 | 275,995 | 0.40% | NEW | 11.2 M | ||
Metsera Inc. | T. Rowe Price Health Sciences Fund | 26.89 | 1,118,110 | 1.06% | NEW | 30.1 M | ||
Neurocrine Biosciences, Inc. | T. Rowe Price Health Sciences Fund | 111.92 | 564,134 | 0.57% | 0.04 | 63.1 M | ||
Natera Inc | T. Rowe Price Health Sciences Fund | 138.62 | 596,239 | 0.44% | 0.05 | 82.7 M | ||
NovoCure Ltd | T. Rowe Price Health Sciences Fund | 17.81 | 634,591 | 0.58% | -0.65 | 11.3 M | ||
Orchestra BioMed Holdings Inc | T. Rowe Price Health Sciences Fund | 4.22 | 305,237 | 0.81% | -0.06 | 1.3 M | ||
BeiGene Ltd - ADR | T. Rowe Price Health Sciences Fund | 266.15 | 792,551 | 0.74% | 0.04 | 210.9 M | ||
ORIC Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 5.76 | 973,193 | 1.37% | 0.03 | 5.6 M | ||
Oruka Therapeutics Inc. | T. Rowe Price Health Sciences Fund | 12.50 | 786,144 | 2.10% | -1.09 | 9.8 M | ||
Oscar Health Inc - Ordinary Shares - Class A | T. Rowe Price Health Sciences Fund | 12.91 | 2,548,842 | 1.02% | -0.26 | 32.9 M | ||
Pacific Biosciences of California Inc | T. Rowe Price Health Sciences Fund | 1.15 | 911,467 | 0.31% | -0.03 | 1.0 M | ||
Vaxcyte Inc | T. Rowe Price Health Sciences Fund | 32.94 | 1,029,426 | 0.80% | -0.13 | 33.9 M | ||
Penumbra Inc | T. Rowe Price Health Sciences Fund | 261.53 | 618,115 | 1.60% | 0.04 | 161.7 M | ||
Pliant Therapeutics Inc | T. Rowe Price Health Sciences Fund | 1.38 | 363,838 | 0.59% | -0.06 | 502.1 K | ||
Praxis Precision Medicines Inc | T. Rowe Price Health Sciences Fund | 38.29 | 314,389 | 1.56% | NEW | 12.0 M | ||
Procept BioRobotics Corp | T. Rowe Price Health Sciences Fund | 56.13 | 461,782 | 0.84% | 0.02 | 25.9 M | ||
Prelude Therapeutics Inc | T. Rowe Price Health Sciences Fund | 0.82 | 716,240 | 1.30% | -0.09 | 587.3 K | ||
Prothena Corporation plc | T. Rowe Price Health Sciences Fund | 12.18 | 288,190 | 0.54% | -0.14 | 3.5 M | ||
Protagonist Therapeutics Inc | T. Rowe Price Health Sciences Fund | 47.72 | 1,027,442 | 1.67% | -0.07 | 49.0 M | ||
Ultragenyx Pharmaceutical Inc. | T. Rowe Price Health Sciences Fund | 36.24 | 810,966 | 0.88% | 0.14 | 29.4 M | ||
Rocket Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 6.62 | 935,595 | 0.88% | 0.02 | 6.2 M | ||
Regeneron Pharmaceuticals, Inc. | T. Rowe Price Health Sciences Fund | 637.32 | 316,564 | 0.29% | -0.03 | 201.8 M | ||
Replimune Group Inc | T. Rowe Price Health Sciences Fund | 9.91 | 1,696,714 | 2.20% | -0.03 | 16.8 M | ||
Repligen Corp. | T. Rowe Price Health Sciences Fund | 128.18 | 229,453 | 0.41% | -0.04 | 29.4 M | ||
Relay Therapeutics Inc | T. Rowe Price Health Sciences Fund | 2.60 | 802,368 | 0.47% | -0.15 | 2.1 M | ||
Avidity Biosciences Inc | T. Rowe Price Health Sciences Fund | 29.66 | 2,492,128 | 2.07% | -0.14 | 73.9 M | ||
Revolution Medicines Inc | T. Rowe Price Health Sciences Fund | 35.03 | 1,636,022 | 0.88% | 0.02 | 57.3 M | ||
Revvity Inc. | T. Rowe Price Health Sciences Fund | 105.28 | 421,963 | 0.35% | 0.02 | 44.4 M | ||
Rhythm Pharmaceuticals Inc. | T. Rowe Price Health Sciences Fund | 52.98 | 290,743 | 0.46% | NEW | 15.4 M | ||
Sana Biotechnology Inc | T. Rowe Price Health Sciences Fund | 1.56 | 2,114,603 | 0.94% | 0.07 | 3.3 M | ||
Soleno Therapeutics Inc | T. Rowe Price Health Sciences Fund | 73.35 | 269,656 | 0.59% | NEW | 19.8 M | ||
Sanofi - ADR | T. Rowe Price Health Sciences Fund | 54.75 | 2,713,528 | 0.11% | 0.02 | 148.6 M | ||
Scholar Rock Holding Corp | T. Rowe Price Health Sciences Fund | 31.32 | 2,147,214 | 2.27% | 0.18 | 67.3 M | ||
SpringWorks Therapeutics Inc | T. Rowe Price Health Sciences Fund | 44.86 | 699,478 | 0.93% | -0.07 | 31.4 M | ||
Stryker Corp. | T. Rowe Price Health Sciences Fund | 368.26 | 1,505,000 | 0.39% | 0.00 | 554.2 M | ||
Spyre Therapeutics Inc. | T. Rowe Price Health Sciences Fund | 16.70 | 217,702 | 0.36% | -0.30 | 3.6 M | ||
Bio-Techne Corp | T. Rowe Price Health Sciences Fund | 58.30 | 726,653 | 0.46% | -0.03 | 42.4 M | ||
Teva- Pharmaceutical Industries Ltd. - ADR | T. Rowe Price Health Sciences Fund | 15.19 | 938,650 | 0.08% | NEW | 14.3 M | ||
Tenet Healthcare Corp. | T. Rowe Price Health Sciences Fund | 134.31 | 615,495 | 0.65% | -0.10 | 82.7 M | ||
Thermo Fisher Scientific Inc. | T. Rowe Price Health Sciences Fund | 492.67 | 1,144,099 | 0.30% | 0.00 | 563.7 M | ||
Entrada Therapeutics Inc | T. Rowe Price Health Sciences Fund | 9.04 | 237,845 | 0.63% | -0.07 | 2.2 M | ||
10x Genomics Inc - Ordinary Shares - Class A | T. Rowe Price Health Sciences Fund | 8.80 | 694,805 | 0.57% | -0.10 | 6.1 M | ||
Unitedhealth Group Inc | T. Rowe Price Health Sciences Fund | 524.63 | 1,556,552 | 0.17% | -0.05 | 816.6 M | ||
United Therapeutics Corp | T. Rowe Price Health Sciences Fund | 304.56 | 266,541 | 0.59% | -0.03 | 81.2 M | ||
Vera Therapeutics Inc - Ordinary Shares - Class A | T. Rowe Price Health Sciences Fund | 24.16 | 1,178,308 | 1.85% | NEW | 28.5 M | ||
Vertex Pharmaceuticals, Inc. | T. Rowe Price Health Sciences Fund | 485.57 | 822,811 | 0.32% | 0.02 | 399.5 M | ||
Voyager Therapeutics Inc | T. Rowe Price Health Sciences Fund | 3.46 | 538,213 | 0.98% | -0.09 | 1.9 M | ||
GeneDx Holdings Corp - Ordinary Shares - Class A | T. Rowe Price Health Sciences Fund | 89.08 | 62,745 | 0.22% | 0.11 | 5.6 M | ||
Wave Life Sciences Ltd. | T. Rowe Price Health Sciences Fund | 8.05 | 1,328,906 | 0.87% | -0.41 | 10.7 M | ||
Xencor Inc | T. Rowe Price Health Sciences Fund | 10.80 | 647,875 | 0.92% | -0.05 | 7.0 M | ||
Zai Lab Limited - ADR | T. Rowe Price Health Sciences Fund | 36.08 | 1,850,845 | 1.71% | 0.04 | 66.8 M | ||
Zentalis Pharmaceuticals Inc | T. Rowe Price Health Sciences Fund | 1.62 | 592,449 | 0.83% | -0.08 | 959.8 K | ||
Hologic, Inc. | 61.72 | - | Investor holds below 1% | |||||
Immatics N.V | 4.48 | - | Investor holds below 1% | |||||
Rapport Therapeutics Inc. | 9.71 | - | Investor holds below 1% | |||||
IGM Biosciences Inc | 1.15 | - | Investor holds below 1% | |||||
Sage Therapeutics Inc | 8.02 | - | Investor holds below 1% | |||||
Novo Nordisk - ADR | 68.01 | - | Investor holds below 1% | |||||
Biomarin Pharmaceutical Inc. - Registered Shares | 70.22 | - | Investor holds below 1% |